UNASSIGNED: Using the IQVIA Medical Research Data (IMRD), patients with back pain were identified (study period: 01 January 2006 to 31 December 2015) using diagnostic records and analgesics prescriptions (n = 133,341), and propensity score matched 1:1 to patients without back pain. The annual incremental costs of back pain associated with consultations and prescriptions were estimated and extrapolated to a national level. Sensitivity analysis was conducted by restricting the study population to the most recent diagnosis of back pain. Variations in cost were assessed stratified by gender, age-groups, deprivation, and comorbidity categories.
UNASSIGNED: The mean age was 57 years, and 62% were females in both the case and control groups. The total incremental healthcare costs associated with back pain was £32.5 million in 2015 (£35.9 million in 2020), with per-patient cost of £244 (£265 in 2020) per year. On a national level, this translated to an estimated £3.2 billion (£3.5 billion in 2020). Eighty percent of the costs were attributed to consultations; and female gender, older age, higher deprivation, and higher comorbidity were all associated with increased mean healthcare costs of patients with back pain.
UNASSIGNED: Our findings confirm the substantial healthcare costs attributed to back pain, even with primacy care costs only. The data also revealed significant cost variations across socio-demographic and clinical factors.
■使用IQVIA医学研究数据(IMRD),使用诊断记录和镇痛药处方(n=133,341)确定背痛患者(研究期间:2006年1月1日至2015年12月31日),与没有背痛的患者的倾向评分为1:1。估计了与咨询和处方相关的背痛的年度增量成本,并将其推断到国家一级。敏感性分析是通过将研究人群限制在最近的背痛诊断中进行的。成本的变化按性别分层评估,年龄组,剥夺,和合并症类别。
■平均年龄为57岁,在病例组和对照组中,62%为女性。与背痛相关的总增量医疗费用在2015年为3250万英镑(2020年为3590万英镑),每位患者每年的费用为244英镑(2020年为265英镑)。在国家层面,这相当于估计32亿英镑(2020年为35亿英镑)。80%的费用归因于咨询;女性,年龄较大,更高的剥夺,和较高的合并症均与背痛患者的平均医疗费用增加相关.
■我们的研究结果证实了背痛导致的大量医疗费用,即使只有首要护理费用。数据还显示,社会人口统计学和临床因素之间的成本差异很大。